Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

W.F. Lems; M.C. Lodder; P. Lips; J.W.J. Bijlsma; P. Geusens; N. Schrameijer; C.M. van de Ven; B.A.C. Dijkmans

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Translated title of the contribution: Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

W.F. Lems, M.C. Lodder, P. Lips, J.W.J. Bijlsma, P. Geusens, N. Schrameijer, C.M. van de Ven, B.A.C. Dijkmans

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Original language	Undefined/Unknown
Pages (from-to)	716-723
Number of pages	8
Journal	Osteoporosis International
Volume	17
Publication status	Published - 2006

Cite this

Lems, W. F., Lodder, M. C., Lips, P., Bijlsma, J. W. J., Geusens, P., Schrameijer, N., van de Ven, C. M., & Dijkmans, B. A. C. (2006). Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Osteoporosis International, 17, 716-723.

@article{da11e10f30894524b73ef82830067f50,

title = "Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.",

author = "W.F. Lems and M.C. Lodder and P. Lips and J.W.J. Bijlsma and P. Geusens and N. Schrameijer and {van de Ven}, C.M. and B.A.C. Dijkmans",

year = "2006",

language = "Undefined/Unknown",

volume = "17",

pages = "716--723",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Lems, WF, Lodder, MC, Lips, P, Bijlsma, JWJ, Geusens, P, Schrameijer, N, van de Ven, CM & Dijkmans, BAC 2006, 'Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.', Osteoporosis International, vol. 17, pp. 716-723.

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. / Lems, W.F.; Lodder, M.C.; Lips, P. et al.
In: Osteoporosis International, Vol. 17, 2006, p. 716-723.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

AU - Lems, W.F.

AU - Lodder, M.C.

AU - Lips, P.

AU - Bijlsma, J.W.J.

AU - Geusens, P.

AU - Schrameijer, N.

AU - van de Ven, C.M.

AU - Dijkmans, B.A.C.

PY - 2006

Y1 - 2006

M3 - Article

SN - 0937-941X

VL - 17

SP - 716

EP - 723

JO - Osteoporosis International

JF - Osteoporosis International

ER -